| Rivaroxaban in patients with a recent acute coronary syndrome JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ... New England Journal of Medicine 366 (1), 9-19, 2012 | 2440 | 2012 |
| A randomized trial of therapies for type 2 diabetes and coronary artery disease BARI 2D Study Group New England Journal of Medicine 360 (24), 2503-2515, 2009 | 2190 | 2009 |
| Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome DA Ehrmann, DJ Schneider, BE Sobel, MK Cavaghan, J Imperial, ... The Journal of Clinical Endocrinology & Metabolism 82 (7), 2108-2116, 1997 | 693 | 1997 |
| Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients JB McGill, DJ Schneider, CL Arfken, CL Lucore, BE Sobel Diabetes 43 (1), 104-109, 1994 | 418 | 1994 |
| International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies DJ Angiolillo, F Rollini, RF Storey, DL Bhatt, S James, DJ Schneider, ... Circulation 136 (20), 1955-1975, 2017 | 391 | 2017 |
| Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor … BE Sobel, J Woodcock-Mitchell, DJ Schneider, RE Holt, K Marutsuka, ... Circulation 97 (22), 2213-2221, 1998 | 384 | 1998 |
| The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart … BR Chaitman, RM Hardison, D Adler, S Gebhart, M Grogan, S Ocampo, ... Circulation 120 (25), 2529-2540, 2009 | 301* | 2009 |
| Factors contributing to increased platelet reactivity in people with diabetes DJ Schneider Diabetes care 32 (4), 525-527, 2009 | 274 | 2009 |
| Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients DJ Schneider, TK Nordt, BE Sobel Diabetes 42 (1), 1-7, 1993 | 266 | 1993 |
| High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients PA Ades, PD Savage, MJ Toth, J Harvey-Berino, DJ Schneider, JY Bunn, ... Circulation 119 (20), 2671-2678, 2009 | 251 | 2009 |
| Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease. TK Nordt, DJ Schneider, BE Sobel Circulation 89 (1), 321-330, 1994 | 227 | 1994 |
| Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects J Calles-Escandon, SA Mirza, BE Sobel, DJ Schneider Diabetes 47 (2), 290-293, 1998 | 226 | 1998 |
| Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus FK Keating, BE Sobel, DJ Schneider The American journal of cardiology 92 (11), 1362-1365, 2003 | 217 | 2003 |
| Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states. DJ Schneider, BE Sobel Proceedings of the National Academy of Sciences 88 (22), 9959-9963, 1991 | 213 | 1991 |
| Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention SS Kabbani, MW Watkins, T Ashikaga, EF Terrien, PA Holoch, BE Sobel, ... Circulation 104 (2), 181-186, 2001 | 187 | 2001 |
| Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cells DJ Schneider, TK Nordt, BE Sobel Diabetes 41 (7), 890-895, 1992 | 187 | 1992 |
| Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. TK Nordt, KJ Klassen, DJ Schneider, BE Sobel Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 13 (12), 1822 …, 1993 | 171 | 1993 |
| Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet … DJ Angiolillo, DJ Schneider, DL Bhatt, WJ French, MJ Price, JF Saucedo, ... Journal of thrombosis and thrombolysis 34, 44-55, 2012 | 170 | 2012 |
| wnt3a but not wnt11 supports self-renewal of embryonic stem cells DK Singla, DJ Schneider, MM LeWinter, BE Sobel Biochemical and biophysical research communications 345 (2), 789-795, 2006 | 162 | 2006 |
| Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis BE Sobel, DJ Taatjes, DJ Schneider Arteriosclerosis, thrombosis, and vascular biology 23 (11), 1979-1989, 2003 | 160 | 2003 |
Friederike Kyra KeatingProfessor of Medicine, University of VermontVerified email at uvmhealth.org
